We're joining the Society for Endocrinology at their annual conference - back to a face-to-face format after CV19.

Visit our stand for further details on :

  • our award-winning venesection best practice guidance, endorsed by the Royal College of Nursing
  • our free hospital/clinic packs of venesection diaries, patient information, telephone helpline and leaflets
  • our 2022 “Cost of illness” report on the £470 million annual cost of GH to the UK healthcare system
  • our free clinician training events and education programme

Genetic haemochromatosis is the UK’s most common genetic condition. Although it is commonplace, the condition is significantly under-diagnosed in the UK. The NHS is caring for just 20,000[i] people with genetic haemochromatosis.

Untreated, the condition can lead to iron overload, where the body is unable to process excess iron. Excess iron is extremely toxic. Genetic haemochromatosis can cause liver disease, cancer, heart disease, chronic fatigue, diabetes, severe joint pain, sexual health issues and neurological issues.

Early diagnosis saves lives. Diagnosed early, haemochromatosis is manageable and not life-limiting. Treatment is simple and cost effective.

[i] HUK Freedom of Information Study (2020) – Neil McClements (Haemochromatosis UK) & Gerri Mortimore (University of Derby)